For patients with symptomatic aortic regurgitation at high surgical risk, a transcatheter aortic valve replacement system ...

The solution? TAVR, or Transcatheter Aortic Valve Replacement, a procedure Providence Alaska Medical Center introduced to patients 10 years ago and remains the only facility in the state offering it.

Transscatheter aortic valve replacement is a novel way to replace a diseased aortic valve without a median sternotomy. The first human TAVR was performed by Dr. Cribier in 2002. [33] There have ...

The 24-month postprocedure risk of death or stroke was 13.7% in those who had delayed TAVI and who were diagnosed with acute valve syndrome at the time of aortic valve replacement (AVR ... patients ...

Solo Pace announced today that it received FDA clearance for its SoloPace Control System for temporary pacing in TAVR ...

One of the primary challenges of percutaneous valve ... which a prosthetic valve loaded onto a balloon catheter can be passed over a wire across the stenotic aortic valve. The other great ...

Transcatheter Aortic Valve Replacement Market outlook through 2035, highlighting key trends, growth drivers, challenges, and future opportunities ...

Medtronic has reported late-breaking data from the randomised Evolut Low Risk Trial’s five-year outcomes of the Evolut transcatheter aortic valve replacement (TAVR) system in low-risk aortic ...

Vivasure hope to find room in a competitive market with its surtureless implant that is absorbed 180 days after vessel ...

Vivasure Medical®, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced ...

Vivasure Medical, an Ireland-based developer of fully absorbable technology for percutaneous vessel closure, announced ...

Vivasure Medical announced today that it received CE mark approval for its PerQseal Elite vascular closure system.